Wells Fargo & Company Provention Bio, Inc. Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$6.7 - $24.21 $25,104 - $90,714	-3,747 Reduced 6.26%	56,101 $1.35 Million
Q4 2022 Feb 13, 2023	BUY	$4.52 - $10.57 $247,189 - $578,052	54,688 Added 1059.84%	59,848 $632,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.62 $1,258 - $2,062	-367 Reduced 6.64%	5,160 $23,000
Q2 2022 Aug 12, 2022	SELL	$3.65 - $7.3 $15,027 - $30,054	-4,117 Reduced 42.69%	5,527 $22,000
Q1 2022 May 16, 2022	SELL	$3.4 - $7.88 $70,230 - $162,769	-20,656 Reduced 68.17%	9,644 $71,000
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $105,673 - $139,700	18,904 Added 165.88%	30,300 $170,000
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $77,468 - $114,012	-13,687 Reduced 54.57%	11,396 $73,000
Q2 2021 Aug 16, 2021	SELL	$6.71 - $11.04 $11,668 - $19,198	-1,739 Reduced 6.48%	25,083 $212,000
Q1 2021 May 13, 2021	SELL	$10.12 - $19.45 $265,002 - $509,317	-26,186 Reduced 49.4%	26,822 $281,000
Q4 2020 Feb 09, 2021	BUY	$11.79 - $18.94 $221,545 - $355,901	18,791 Added 54.92%	53,008 $898,000
Q3 2020 Nov 05, 2020	SELL	$10.34 - $15.2 $124,503 - $183,023	-12,041 Reduced 26.03%	34,217 $439,000
Q2 2020 Aug 13, 2020	BUY	$7.81 - $17.0 $50,655 - $110,262	6,486 Added 16.31%	46,258 $652,000
Q1 2020 May 14, 2020	BUY	$5.42 - $17.75 $215,564 - $705,953	39,772 New	39,772 $366,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.